Global Veterinary Biologics Market to See Strong Expansion with Promising Opportunities from 2026–2035

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Appetite Stimulant Market From 2026 To 2030?

The veterinary biologics market has demonstrated robust growth over recent years. It is anticipated to expand from $13.61 billion in 2025 to $14.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. This historical expansion can be attributed to several factors, including the increasing prevalence of livestock diseases, a growing companion animal population, significant advancements in vaccine development, heightened government funding for veterinary research, and the ongoing expansion of veterinary healthcare infrastructure.

The veterinary biologics market is anticipated to show significant expansion in the coming years. It is projected to climb to $20.03 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.2%. This projected growth can be linked to several factors such as technological advancements in biologics, the increasing use of precision medicine for animals, a rise in global pet ownership, growing understanding of zoonotic diseases, and the expansion of the veterinary diagnostics market. Important trends during this period are expected to be an increased emphasis on preventive animal healthcare, the growing adoption of rapid diagnostic solutions, the expansion of companion animal biologics, the integration of immunomodulators in veterinary treatments, and a rising demand for livestock disease management solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

What Key Drivers Are Influencing The Growth Of The Appetite Stimulant Market?

The escalating trend in pet adoption is projected to stimulate the expansion of the veterinary biologics market in the foreseeable future. Pet adoption involves assuming care for a domesticated animal, frequently from shelters or rescue groups, with the aim of providing a stable and loving environment. The increase in pet adoptions stems from a heightened understanding of animal welfare, as individuals increasingly acknowledge the advantages of giving homes to rescued animals, opting for adoption rather than purchase. Veterinary biologics play a crucial role by preventing various infectious diseases in pets, fostering immunity, managing zoonotic illnesses, extending lifespan and improving quality of life, decreasing veterinary healthcare expenditures, promoting reproductive health in pets, and providing more precise and tailored treatment approaches. Illustrating this trend, data from March 2025 by the American Pet Products Association, a US-based non-profit organization, indicates that ninety-four (94) million U.S. households possess at least one pet, a rise from eighty-two (82) million in 2023. Consequently, the rising rate of pet adoption is a significant impetus behind the growth of the veterinary biologics market.

Which Segments Are Included In The Analysis Of The Appetite Stimulant Market?

The veterinary biologics market covered in this report is segmented –

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants

4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Which Trends Are Impacting The Growth Of The Veterinary Biologics Market?

Leading companies active in the veterinary biologics market are concentrating on developing innovative biologics, such as vaccines, to improve animal well-being and prevent diseases. A vaccine is a substance that stimulates the immune system to recognize and combat specific pathogens. It helps prevent infectious diseases by providing acquired immunity. For instance, in August 2024, Merck Animal Health, a US-based global animal health company, introduced an experimental autogenous vaccine targeting avian metapneumovirus (aMPV) type B, having received approval from the U.S. Department of Agriculture (USDA) for its manufacturing and sale. This vaccine, developed in collaboration with Cambridge Technologies, aims to combat the severe respiratory issues caused by aMPV type B in poultry, which have led to significant economic losses since late 2023. Produced at a state-of-the-art facility in Minnesota, the vaccine features an oil and water emulsion formulation designed to minimize post-vaccination tissue reactions, addressing a critical gap in the market as no commercially licensed vaccines were previously available.

Which Key Industry Participants Are Active In The Appetite Stimulant Market?

Major companies operating in the veterinary biologics market are Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA, Indian Immunologicals Ltd., Vetoquinol, Beijing SVA Vaccines Serums

Read the full veterinary biologics market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Appetite Stimulant Market?

North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Appetite Stimulant Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp

Browse Through More Reports Similar to the Global Veterinary Biologics Market 2026, By The Business Research Company

Veterinary Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-medicine-global-market-report

Veterinary Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Veterinary Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795